The Secreted Ly6/uPAR-Related Protein 1 (Slurp1) Modulates Corneal Angiogenic Inflammation Via NF-κB Signaling
Investigative Opthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.1.37 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, 2024. Verfasst von Sudha Swamynathan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States. Hauptthemen laut MEDLINE: Corneal Neovascularization, Keratitis, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
- Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
Förderung
- NEI NIH HHS
Zitieren
APA
Swamynathan, S., Campbell, G., Sohnen, P., Kaur, S., St Leger, A. J., & Swamynathan, S. K. (2024). The Secreted Ly6/uPAR-Related Protein 1 (Slurp1) Modulates Corneal Angiogenic Inflammation Via NF-κB Signaling. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.65.1.37
Vancouver
Swamynathan S, Campbell G, Sohnen P, Kaur S, St Leger AJ, Swamynathan SK. The Secreted Ly6/uPAR-Related Protein 1 (Slurp1) Modulates Corneal Angiogenic Inflammation Via NF-κB Signaling. Investigative Opthalmology & Visual Science. 2024. doi:10.1167/iovs.65.1.37
BibTeX
@article{Swamynathan2024,
author = {Swamynathan, Sudha and Campbell, Gregory and Sohnen, Peri and Kaur, Satinder and St Leger, Anthony J and Swamynathan, Shivalingappa K},
title = {The Secreted Ly6/uPAR-Related Protein 1 (Slurp1) Modulates Corneal Angiogenic Inflammation Via NF-κB Signaling},
journal = {Investigative Opthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.1.37}
}
EUVIMED